Valproic acid oral - Banner Life Sciences

Drug Profile

Valproic acid oral - Banner Life Sciences

Alternative Names: Stavzor; Stavzor ER; Valproic acid delayed-release capsules (Stavzor); Valproic acid extended-release capsules (Stavzor ER)

Latest Information Update: 01 Dec 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Banner Pharmacaps
  • Developer Banner Life Sciences; Banner Pharmacaps
  • Class Antiepileptic drugs; Antimigraines; Nootropics; Small molecules
  • Mechanism of Action 4-aminobutyrate transaminase inhibitors; Glutamate decarboxylase stimulants; Neurotransmitter modulators; Sodium channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Bipolar disorders; Epilepsy; Migraine

Most Recent Events

  • 01 Dec 2016 Banner Pharmacaps is now called Banner Life Sciences
  • 15 Mar 2016 Biomarkers information updated
  • 14 Dec 2012 Banner Pharmacaps has been acquired by Patheon
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top